IE51637B1 - Pharmaceutical preparation - Google Patents

Pharmaceutical preparation

Info

Publication number
IE51637B1
IE51637B1 IE2354/81A IE235481A IE51637B1 IE 51637 B1 IE51637 B1 IE 51637B1 IE 2354/81 A IE2354/81 A IE 2354/81A IE 235481 A IE235481 A IE 235481A IE 51637 B1 IE51637 B1 IE 51637B1
Authority
IE
Ireland
Prior art keywords
prostaglandin
hydrogen
acid
polyethylene glycol
capsule according
Prior art date
Application number
IE2354/81A
Other languages
English (en)
Other versions
IE812354L (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IE812354L publication Critical patent/IE812354L/xx
Publication of IE51637B1 publication Critical patent/IE51637B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IE2354/81A 1980-10-09 1981-10-08 Pharmaceutical preparation IE51637B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/195,575 US4310543A (en) 1980-10-09 1980-10-09 Prostaglandin compositions

Publications (2)

Publication Number Publication Date
IE812354L IE812354L (en) 1982-04-09
IE51637B1 true IE51637B1 (en) 1987-01-21

Family

ID=22721933

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2354/81A IE51637B1 (en) 1980-10-09 1981-10-08 Pharmaceutical preparation

Country Status (13)

Country Link
US (1) US4310543A (cs)
EP (1) EP0049852B1 (cs)
JP (1) JPS5793911A (cs)
AT (1) ATE14981T1 (cs)
AU (1) AU547175B2 (cs)
CA (1) CA1176567A (cs)
DE (1) DE3171928D1 (cs)
DK (1) DK442881A (cs)
IE (1) IE51637B1 (cs)
IL (1) IL63960A (cs)
NZ (1) NZ198533A (cs)
PH (1) PH17073A (cs)
ZA (1) ZA816852B (cs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA835226B (en) * 1982-07-19 1985-03-27 Syntex Inc Pge-type compositions encapsulated by acid isolated gelatin
US4431833A (en) * 1982-12-27 1984-02-14 American Cyanamid Company Prostaglandin and hydroxylated fatty acid ester formulations
FR2549371B1 (fr) * 1983-07-20 1985-09-13 Sanofi Sa Nouvelle composition pharmaceutique contenant de l'acide valproique ou un de ses sels
WO1985003439A1 (en) * 1984-02-08 1985-08-15 R.P. Scherer Corporation Acetaminophen gelatin capsule providing rapid onset of therapeutic activity upon oral administration
DE3438830A1 (de) * 1984-10-23 1986-04-30 Rentschler Arzneimittel Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung
NO882653D0 (no) * 1988-06-15 1988-06-15 Apothekernes Lab Doseringsform.
ATE114470T1 (de) * 1990-05-22 1994-12-15 R Tech Ueno Ltd Behandlung von intraocularem druck mit einer synergistischen kombination zur ophthalmischen verwendung.
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
US5962522A (en) * 1997-09-05 1999-10-05 Avmax, Inc. Propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
US6180666B1 (en) 1997-09-05 2001-01-30 Anmax, Inc. Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds
AU6107500A (en) * 1999-07-13 2001-01-30 Avmax, Inc. Improvement of bioavailability with vitamin c fatty acid esters
KR100649860B1 (ko) * 2000-09-01 2006-11-24 주식회사종근당 알프로스타딜 경점막 및 경피흡수제제
EP1321144B1 (en) * 2000-09-13 2010-12-08 Santen Pharmaceutical Co., Ltd. Eye drops
US20060199863A1 (en) * 2003-07-31 2006-09-07 Santen Pharmaceutical Co., Ltd. Product containing prostaglandin
CN102552917A (zh) 2003-08-13 2012-07-11 比奥孔有限公司 用于治疗剂的微-粒子脂肪酸盐固体剂量制剂
US20050123602A1 (en) * 2003-09-25 2005-06-09 Michaelis Arthur F. Rifalazil formulations
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
CN102526064A (zh) * 2004-12-09 2012-07-04 参天制药株式会社 含有分子内具有氟原子的前列腺素的制品
ATE555792T1 (de) * 2004-12-24 2012-05-15 Santen Pharmaceutical Co Ltd Prostaglandin f2 alpha derivat enthaltende produkte
CN101437518A (zh) * 2006-04-06 2009-05-20 活跃生物药物学有限公司 药物组合物及其应用
EP2178516B1 (en) 2007-07-19 2015-09-09 R-Tech Ueno, Ltd. Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound
CA2702935A1 (en) * 2007-10-19 2009-04-23 Purdue Research Foundation Solid formulations of crystalline compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2889252A (en) * 1956-05-14 1959-06-02 American Cyanamid Co Gelatin capsule containing hexylresorcinol and a lower polyalkylene glycol
ZA721937B (en) * 1971-10-22 1972-12-27 Upjohn Co Pharmaceutical preparations and uses thereof
CA1043259A (en) * 1972-12-08 1978-11-28 Geoffrey F. Thompson Medicament preparations and vehicles therefor
US3932634A (en) * 1973-06-28 1976-01-13 Pfizer Inc. High potency vitamin water dispersible formulations
US4052446A (en) * 1973-08-06 1977-10-04 Hoffmann-La Roche Inc. 11,16-substituted prostaglandins
JPS6019734B2 (ja) * 1977-05-12 1985-05-17 三共株式会社 安定なプロスタグランジンｅ類製剤の製法
JPS6046094B2 (ja) * 1977-06-01 1985-10-14 科研製薬株式会社 安定化されたプロスタグランジンｅ類粉末製剤
FI790043A7 (fi) * 1978-01-17 1979-07-18 Sandoz Ag Prostaglandiner innehaollande terapeutisk sammansaettning

Also Published As

Publication number Publication date
EP0049852A3 (en) 1983-01-26
ZA816852B (en) 1982-09-29
EP0049852B1 (de) 1985-08-21
NZ198533A (en) 1984-12-14
JPH032848B2 (cs) 1991-01-17
PH17073A (en) 1984-05-24
US4310543A (en) 1982-01-12
ATE14981T1 (de) 1985-09-15
CA1176567A (en) 1984-10-23
IL63960A (en) 1985-05-31
AU547175B2 (en) 1985-10-10
JPS5793911A (en) 1982-06-11
DK442881A (da) 1982-04-10
IE812354L (en) 1982-04-09
EP0049852A2 (de) 1982-04-21
DE3171928D1 (en) 1985-09-26
AU7606881A (en) 1982-04-22
IL63960A0 (en) 1981-12-31

Similar Documents

Publication Publication Date Title
US4310543A (en) Prostaglandin compositions
CA1203172A (en) Propylene glycol diester solutions of pge-type compounds
EP0063367B1 (en) Acetal stabilized prostaglandin compositions
US4410545A (en) Carbonate diester solutions of PGE-type compounds
KR100514963B1 (ko) 4,5-에폭시모르피난 유도체를 함유하는 안정한 의약품 조성물
US4328245A (en) Carbonate diester solutions of PGE-type compounds
EP0179808A1 (en) PHARMACEUTICAL COMPOSITION SUITABLE FOR TREATMENT OR PROPHYLAXIS OF CARDIAC CONDITIONS.
RU1829935C (ru) Способ получени флунаризинсодержащей композиции
US4386077A (en) Pharmaceutical composition for oral administration containing cytidine diphosphocholine
EP0298192B1 (en) Stable, injectable solutions of vincristine salts
US4784855A (en) Pharmaceutical compositions and suppository
CN115737571A (zh) 一种喷他佐辛制剂及其制备方法和用途
US4389414A (en) Prostaglandin compositions
US4344950A (en) Parenteral solvent and a process for the preparation of stable solutions containing same
US3627886A (en) Methods of solubilizing coumermycin employing urea, dimethylacetamide or mixtures thereof
WO2021099901A1 (en) Stable topical pharmaceutical composition
US3809761A (en) Method for reducing plasma lipid levels
EP0533938A1 (en) Composition for rectal administration of difficultly absorbable peptide
US4882356A (en) Stable injectable antiemetic compositions
CA1282703C (en) Stable injectable antiemetic compositions
JPH08208598A (ja) プロスタグランジン類組成物
JPWO1990003173A1 (ja) 活性型ビタミンｄ３類の安定な水性液剤
KR830000677A (ko) 물질의 조성물